Fatty liver is a risk factor for liver metastasis in Chinese patients with non-small cell lung cancer

PeerJ - Tập 7 - Trang e6612
Wenyu Wu1,2, Haiyan Liao1, Weilin Ye1, Xi Li1, Jian Zhang1, Junguo Bu3
1Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
2Target and Interventional Therapy Department of Oncology, First People’s Hospital of Foshan, Foshan, China
3Department of Radiation Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China

Tóm tắt

Background The hepatic microenvironment, which may include chronic inflammation and fibrosis, is considered to contribute to the development of liver metastases. Hepatic steatosis (HS) might cause liver inflammation and fibrosis. However, to date, no studies have investigated the impact of HS on liver metastasis in patients with non-small cell lung cancer (NSCLC). Methods A retrospective cohort study was performed on patients who received NSCLC treatment at two hospitals affiliated with the Southern Medical University from January 2005 to December 2015. The patients were grouped according to the presence of HS. The clinicopathological features of patients between the two groups were compared. The effect of HS on liver metastasis and overall metastasis was evaluated, adjusting for other confounders using Cox regression analyses. Results In total, 1,873 patients with NSCLC with no distant metastases were included in this study, and 408 (21.8%) patients were diagnosed with HS (at the time of diagnosis or before diagnosis). Liver metastases occurred in 166 (8.9%) patients. Liver metastasis-free survival was significantly worse in the study (HS) group (hazard ratio (HR) 1.42; (95% CI [1.03–1.96]); P = 0.031). Multivariate regression analysis demonstrated that HS was an independent risk factor for liver metastasis (HR 1.43; 95% CI [1.02–2.01]; P = 0.039). However, HS was not associated with overall metastasis of NSCLC (HR 0.99; 95% CI [0.84–1.17]; P = 0.895). Conclusion Hepatic steatosis was an independent predictor of liver metastasis from in patients with NSCLC.

Từ khóa


Tài liệu tham khảo

Bellentani, 2017, The epidemiology of non-alcoholic fatty liver disease, Liver International, 37, 81, 10.1111/liv.13299

Chan, 2017, Influencing the tumor microenvironment: a phase II study of copper depletion using tetrathiomolybdate in patients with breast cancer at high risk for recurrence and in preclinical models of lung metastases, Clinical Cancer Research, 23, 666, 10.1158/1078-0432.CCR-16-1326

Coussens, 2002, Inflammation and cancer, Nature, 420, 860, 10.1038/nature01322

Dasarathy, 2009, Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study, Journal of Hepatology, 51, 1061, 10.1016/j.jhep.2009.09.001

Eveno, 2015, Proof of prometastatic niche induction by hepatic stellate cells, Journal of Surgical Research, 194, 496, 10.1016/j.jss.2014.11.005

Fan, 2017, New trends on obesity and NAFLD in Asia, Journal of Hepatology, 67, 862, 10.1016/j.jhep.2017.06.003

Hamady, 2013, Fatty liver disease as a predictor of local recurrence following resection of colorectal liver metastases, British Journal of Surgery, 100, 820, 10.1002/bjs.9057

Hamaguchi, 2007, The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation, American Journal of Gastroenterology, 102, 2708, 10.1111/j.1572-0241.2007.01526.x

Hardy, 2016, Nonalcoholic fatty liver disease: pathogenesis and disease spectrum, Annual Review of Pathology: Mechanisms of Disease, 11, 451, 10.1146/annurev-pathol-012615-044224

Jiang, 2017, Characterization of liver metastasis and its effect on targeted therapy in EGFR-mutant NSCLC: a multicenter study, Clinical Lung Cancer, 18, 631, 10.1016/j.cllc.2017.04.015

Langley, 2011, The seed and soil hypothesis revisited—the role of tumor-stroma interactions in metastasis to different organs, International Journal of Cancer, 128, 2527, 10.1002/ijc.26031

Li, 2015, Kupffer cells support Hepatitis B virus–mediated CD8+ T cell exhaustion via Hepatitis B core antigen–TLR2 interactions in mice, Journal of Immunology, 195, 3100, 10.4049/jimmunol.1500839

Lu, 2016, Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: an 8-year follow-up study, World Journal of Gastroenterology, 22, 3663, 10.3748/wjg.v22.i13.3663

Matsusue, 2009, Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis, Annals of Surgical Oncology, 16, 2645, 10.1245/s10434-009-0599-x

Mikuriya, 2015, Fatty liver creates a pro-metastatic microenvironment for hepatocellular carcinoma through activation of hepatic stellate cells, International Journal of Cancer, 136, E3, 10.1002/ijc.29096

Murono, 2013, Hepatic steatosis is associated with lower incidence of liver metastasis from colorectal cancer, International Journal of Colorectal Disease, 28, 1065, 10.1007/s00384-013-1656-2

Lonardo, 2015, Epidemiological modifiers of non-alcoholic fatty liver disease: focus on high-risk groups, Digestive and Liver Disease, 47, 997, 10.1016/j.dld.2015.08.004

LaBrecque, 2014, World gastroenterology organisation global guidelines: nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, Journal of Clinical Gastroenterology, 48, 467, 10.1097/MCG.0000000000000116

Riihimaki, 2014, Metastatic sites and survival in lung cancer, Lung Cancer, 86, 78, 10.1016/j.lungcan.2014.07.020

Shi, 2018, Hypotoxic copper complexes with potent anti-metastatic and anti-angiogenic activities against cancer cells, Dalton Transactions, 47, 5049, 10.1039/C8DT00794B

Siegel, 2016, Cancer statistics, 2016, CA: A Cancer Journal for Clinicians, 66, 7, 10.3322/caac.21332

Tang, 2016, Prognosis and predictors of site of first metastasis after definitive radiation therapy for non-small cell lung cancer, Acta Oncologica, 55, 1022, 10.3109/0284186X.2016.1154602

Tarantino, 2018, Prediction of carotid intima-media thickness in obese patients with low prevalence of comorbidities by serum copper bioavailability, Journal of Gastroenterology and Hepatology, 33, 1511, 10.1111/jgh.14104

VanSaun, 2009, High fat diet induced hepatic steatosis establishes a permissive microenvironment for colorectal metastases and promotes primary dysplasia in a murine model, American Journal of Pathology, 175, 355, 10.2353/ajpath.2009.080703

Wang, 2010, Five-year lung cancer survival: which advanced stage nonsmall cell lung cancer patients attain long-term survival?, Cancer, 116, 1518, 10.1002/cncr.24871

Wu, 2017, Fatty liver decreases the risk of liver metastasis in patients with breast cancer: a two-center cohort study, Breast Cancer Research and Treatment, 166, 289, 10.1007/s10549-017-4411-5

Wu, 2018, Non-alcoholic fatty liver disease incidence, remission and risk factors among a general Chinese population with a 6-year follow-up, Scientific Reports, 8, 7557, 10.1038/s41598-018-25641-z

Zablocka-Slowinska, 2018, Serum and whole blood Zn, Cu and Mn profiles and their relation to redox status in lung cancer patients, Journal of Trace Elements in Medicine and Biology, 45, 78, 10.1016/j.jtemb.2017.09.024

Zhu, 2016, Is non-alcoholic fatty liver disease the risk factor for the occurrence of primary bronchogenic carcinoma [In Chinese], Journal of Practical Hepatology, 19, 683

Thông tin
Thông tin xuất bản

PeerJ

Tập 7

e6612

Thông tin tác giả